Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
5.74
+0.15 (2.68%)
Dec 31, 2025, 12:55 PM EST - Market open
Generation Bio Co. Market Cap
Generation Bio Co. has a market cap or net worth of $38.68 million as of December 31, 2025. Its market cap has decreased by -51.34% in one year.
Market Cap
38.68M
Enterprise Value
-24.99M
1-Year Change
-51.34%
Ranking
Category
Stock Price
$5.74
Market Cap Chart
Since June 12, 2020, Generation Bio Co.'s market cap has decreased from $1.07B to $38.68M, a decrease of -96.39%. That is a compound annual growth rate of -45.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 37.66M | -46.80% |
| Dec 31, 2024 | 70.80M | -35.06% |
| Dec 29, 2023 | 109.03M | -53.31% |
| Dec 30, 2022 | 233.53M | -41.89% |
| Dec 31, 2021 | 401.89M | -68.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 966.79B |
| Johnson & Johnson | 498.51B |
| AbbVie | 406.04B |
| UnitedHealth Group | 300.88B |
| AstraZeneca | 287.28B |
| Novartis AG | 266.00B |
| Merck & Co. | 263.24B |
| Novo Nordisk | 227.63B |